[Clinical evaluation of Butylon by multi-institutional, double-blind method--clinical examination of effective drug combination].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000627:Aminophenols / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D002110:Caffeine / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010628:Phenetidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012457:Salicylamides / Q000008:administration & dosage / Q000627:therapeutic use*; D013831:Thiamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014081:Tooth Extraction
D000627:Aminophenols; D000700:Analgesics; D004338:Drug Combinations; D012457:Salicylamides; C023636:bucetin, caffeine, dibenzoylthiamine, ethenzamide drug combination; D010628:Phenetidine; D002110:Caffeine; D013831:Thiamine